Moreover, Genistein, by reduction of pro-inflammatory mediators (IL-6, tumor necrosis factor- (TNF-) and C-reactive protein (CRP)) in serum and intestine in alloxan-induced diabetic rats, reduces the damage of L-cells and leads to an increase in the expression and secretion of GLP-1[191]
Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis
How much GLP-1 do you take depends on the specific medication prescribed, your treatment indication (type 2 diabetes or weight management), and your individual response to therapy
doi: 10.1111/dom.14126
Severity and combination of symptoms can vary widely between individuals, and may also fluctuate over the course of treatment
And, in my own case, I am definitely guilty of conducting precisely zilch in the way of this sort of preliminary research